Skip to Content

← See all Alertness Aid brands

Alertness Aid by Chain Drug Consortium

Dosage form: tablet
Ingredients: CAFFEINE 200mg
Labeler: Chain Drug Consortium
NDC Code: 68016-680

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Premier Value 44-226

Active ingredient (in each tablet)

Caffeine 200 mg

Purpose

Alertness aid

Uses

helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

Warnings

For occasional use only

Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.

Do not use
  • in children under 12 years
  • as a substitute for sleep

Stop use and ask a doctor if

fatigue or drowsiness persists or continues to recur.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions
  • adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

Other information
  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)
  • see end flap for expiration date and lot number

Inactive ingredients

corn starch, D&C yellow #10 aluminum lake, dextrose, dicalcium phosphate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, silica gel

Questions or comments?

1-800-426-9391

Principal Display Panel

Premier
Value®

NDC 68016-680-16

*COMPARE TO THE ACTIVE INGREDIENT
  IN VIVARIN®

Alertness Aid

Caffeine 200 mg
ALERTNESS AID

Equal to about a cup of coffee

16 Tablets

INDEPENDENTLY TESTED
PV
SATISFACTION GUARANTEED

TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

*This product is not manufactured or distributed by Meda Consumer Healthcare, owner of the registered trademark Vivarin®.
50844         ORG041222621

DISTRIBUTED BY
CHANIN DRUG CONSORTIUM, LLC
UPARC, BLDG. A3, SUITE 338, 1020 WILLIAM PITT WAY
PITTSBURGH, PA 15238    www.chaindrugconsortium.com

If for any reason you are not satisfied with this product, please return it to the store where purchased for a full refund.

Premier Value 44-226

ALERTNESS AID 
caffeine tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-680
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CAFFEINE (CAFFEINE) CAFFEINE200 mg
Inactive Ingredients
Ingredient NameStrength
STARCH, CORN 
D&C YELLOW NO. 10 
DEXTROSE 
FD&C YELLOW NO. 6 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
SILICON DIOXIDE 
Product Characteristics
ColorYELLOWScoreno score
ShapeROUNDSize11mm
FlavorImprint Code44;226
Contains    
Packaging
#Item CodePackage Description
1NDC:68016-680-162 BLISTER PACK in 1 CARTON
18 TABLET in 1 BLISTER PACK
2NDC:68016-680-405 BLISTER PACK in 1 CARTON
28 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34011/21/1996
Labeler - Chain Drug Consortium (101668460)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.038154464PACK(68016-680)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867894MANUFACTURE(68016-680)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867837PACK(68016-680)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.967626305PACK(68016-680)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.868734088PACK(68016-680)

 
Chain Drug Consortium

← See all Alertness Aid brands

Medically reviewed on Jun 15, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide